Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Related Posts
Solana Vs. Ethereum: Investment Giant Fidelity Predicts Who Will Lead In 2025
Fidelity Digital Assets, a subsidiary of global financial services firm Fidelity Investments, has released a new paper titled “2025 Look…
Ethereum Price Readies for Takeoff — Bulls Eye Fresh Highs
Ethereum price started a fresh increase above the $2,485 zone. ETH is now consolidating gains and might soon aim for…
Strategy Discloses $42 Billion Fundraising Plan To Hit 1 Million Bitcoin Target By End Of 2026
Strategy, formerly known as MicroStrategy and led by Michael Saylor, disclosed a new Bitcoin (BTC) acquisition on Monday while simultaneously…